Livedo Reticularis After COVID-19 Vaccination.
- Published in:
- Journal of Rheumatology, 2023, v. 50, n. 5, p. 709, doi. 10.3899/jrheum.220584
- By:
- Publication type:
- Article
Works by Inotani, Satoshi
Results: 16
1
2
Efficacy of urinary [TIMP-2]⋅[IGFBP7], L-FABP, and NGAL levels for predicting community-acquired acute kidney injury in Japanese patients: a single-center, prospective cohort study.
- Published in:
- Clinical & Experimental Nephrology, 2025, v. 29, n. 7, p. 928, doi. 10.1007/s10157-025-02641-8
- By:
- Publication type:
- Article
3
Haematologic malignancy-associated mucocutaneous paraneoplastic syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
4
Jaccoud's arthropathy in the elderly.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
5
Thymic plasma cell neoplasm infiltration in Sjögren’s syndrome with monoclonal gammopathy.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
6
Monoclonal gammopathy of renal significance: overlap of AL amyloidosis and immunotactoid glomerulopathy Open Access.
- Published in:
- QJM: An International Journal of Medicine, 2025, v. 118, n. 4, p. 306, doi. 10.1093/qjmed/hcaf026
- By:
- Publication type:
- Article
7
Knockout of Zeb2 ameliorates progression of renal tubulointerstitial fibrosis in a mouse model of renal ischemia–reperfusion injury.
- Published in:
- Nephrology Dialysis Transplantation, 2022, v. 37, n. 3, p. 454, doi. 10.1093/ndt/gfab311
- By:
- Publication type:
- Article
8
Clinical significance of anti-lipoprotein lipase antibodies in Japanese patients with systemic lupus erythematosus.
- Published in:
- Lupus, 2025, v. 34, n. 7, p. 699, doi. 10.1177/09612033251344051
- By:
- Publication type:
- Article
9
Untitled.
- Published in:
- Lupus, 2022, v. 31, n. 11, p. 1408, doi. 10.1177/09612033221119329
- By:
- Publication type:
- Article
10
Drug reaction with eosinophilia and systemic symptoms/drug‐induced hypersensitivity syndrome (DRESS/DIHS) caused by levofloxacin in a patient with systemic scleroderma, rheumatoid arthritis, and Sjogren syndrome.
- Published in:
- 2019
- By:
- Publication type:
- Case Study
11
Clinical significance of amphiregulin in patients with chronic kidney disease.
- Published in:
- Clinical & Experimental Nephrology, 2024, v. 28, n. 5, p. 421, doi. 10.1007/s10157-023-02445-8
- By:
- Publication type:
- Article
12
Repeated attacks of polyarteritis nodosa in the central nervous system.
- Published in:
- Modern Rheumatology Case Reports, 2019, v. 3, n. 1, p. 30, doi. 10.1080/24725625.2018.1486363
- By:
- Publication type:
- Article
13
Gemcitabine‐induced renal thrombotic microangiopathy.
- Published in:
- Nephrology, 2022, v. 27, n. 8, p. 724, doi. 10.1111/nep.14043
- By:
- Publication type:
- Article
14
Crescentic glomerulonephritis induced by anti‐vascular endothelial growth factor receptor 2 antibody.
- Published in:
- Nephrology, 2022, v. 27, n. 4, p. 384, doi. 10.1111/nep.13969
- By:
- Publication type:
- Article
15
Overlap of Thrombotic Microangiopathy and Mesangial Proliferative Glomerulonephritis Caused by Combination Therapy with Atezolizumab and Bevacizumab.
- Published in:
- Internal Medicine, 2023, v. 62, n. 1, p. 91, doi. 10.2169/internalmedicine.9425-22
- By:
- Publication type:
- Article
16
Primary Superior Lumbar Hernia with Nephrotic-range Orthostatic Proteinuria.
- Published in:
- Internal Medicine, 2022, v. 61, n. 14, p. 2187, doi. 10.2169/internalmedicine.8757-21
- By:
- Publication type:
- Article